Status:
WITHDRAWN
Effects of Curcumin on Markers of Cardiovascular Risk in Patients With CAD
Lead Sponsor:
Universidade Federal Fluminense
Conditions:
Coronary Artery Disease
Oxidative Stress
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
\- General Objective To evaluate the effects of curcumin supplementation on cardiovascular risk markers, inflammation, oxidative stress and functional capacity in participants with coronary artery dis...
Detailed Description
Coronary Artery Disease (CAD) is the leading cause of death worldwide. CAD refers to the pathological process of atherosclerosis that affects the coronary arteries, often leading to obstruction by an ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Non-smokers
- with a previous diagnosis of coronary artery disease and / or altered myocardial scintigraphy, both performed by a cardiologist.
- Exclusion criteria:
- autoimmune and infectious diseases
- pregnant and lactating women
- cancer
- AIDS;
- participants using catabolic drugs, antioxidant vitamin supplements and habitual intake of turmeric and turmeric.
Exclusion
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 10 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04458116
Start Date
May 10 2021
End Date
May 10 2021
Last Update
February 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denise Mafra
Rio de Janeiro, Rio de Janeiro, Brazil, 22260050